Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001628280-26-012395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | VIR | O'Byrne Jason | EVP, CFO | S - Sale | $9.53 | -1,634 | 162.6K | -1.0% | -$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | S | D | 1,634 | $9.53 | 162,615 | D | — | — |